Charles Berry, MD
Gynecology · Hammond, LANPI 1740283258
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 60.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $142 and has fallen 77.5% since, to $32 in 2024. That places this record below the midpoint for gynecology clinicians in LA, where the typical reported total is $879.
Across 29 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$270
- Pfizer$63
- Astellas Pharma US Inc$32
- Therapeuticsmd, Inc.$30
- Ascend Therapeutics US, LLC$24
- Alfasigma USA, Inc.$14
- plus $14 from 2 others
What the payments were for
- Food & beverage$445100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $270 |
| Pfizer | 3 | $63 |
| Astellas Pharma US Inc | 2 | $32 |
| Therapeuticsmd, Inc. | 2 | $30 |
| Ascend Therapeutics US, LLC | 2 | $24 |
| Alfasigma USA, Inc. | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $11 |
| Mayne Pharma Commercial LLC | 1 | $3 |
How this compares
$445 in reported general payments places this provider in the 40th percentile of 37 gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 119 | $12,652 |
| Norethindrone Acetate | 17 | $1,853 |
| Estradiol (Twice Weekly)Estradiol | 18 | $1,465 |
| ProgesteroneProgesterone, Micronized | 57 | $875 |
| ValacyclovirValacyclovir Hcl | 14 | $822 |
| Alendronate Sodium | 15 | $179 |
| Clobetasol Propionate | 11 | $142 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $103 |
| Triamcinolone Acetonide | 19 | $75 |
| Sertraline Hcl | 16 | $50 |
| Clonazepam | 13 | $48 |
| Fluconazole | 12 | $33 |
| Lorazepam | 13 | $30 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Hammond
- Dwan MabryHammond$3K
- Lisa ColonHammond$3K
- Timothy MooneyHammond$273
- Leonard WeatherShreveport$89K
- May ThomasseeLafayette$50K
- William von AlmenNew Orleans$17K
- Albert TydingsCovington$5K
- Alison StewartMetairie$4K
- Stacey ScheibMetairie$4K
- Margie KahnMetairie$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.